Medmira Inc (MIR_CDNX)
MIR_CDNX moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How MIR_CDNX actually reacts to news — the realized, point-in-time move the market made, measured across 31 labeled events over the last three years with zero look-ahead.
MIR_CDNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 0% | 10 |
| 30-min | 0.00% | 10% | 10 |
| 60-min | 0.00% | 10% | 10 |
| to close | 0.00% | 30% | 10 |
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when MIR_CDNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MIR_CDNX's baseline. Nothing else.
Recent MIR_CDNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| MedMira Reports Third Quarter Results FY2026 | Press release | ACCESS Newswire | — | — | |
| MedMira Reports Second Quarter Results FY2025 | Press release | ACCESS Newswire | — | — | |
| MedMira Reports First Quarter Results FY2026 | Press release | ACCESS Newswire | — | — | |
| MedMira Reports FY2025 Fourth Quarter and Year End Financial Results | Press release | ACCESS Newswire | — | — | |
| Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis | Press release | ACCESS Newswire | — | — | |
| MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada | Press release | ACCESS Newswire | — | — | |
| MedMira Reports Second Quarter Results FY2025 | Press release | ACCESS Newswire | — | — | |
| MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense | Press release | ACCESS Newswire | — | — | |
| MedMira Reports Second Quarter Results FY2025 | Press release | ACCESS Newswire | — | — | |
| MedMira Announces Partnership with MediGroup Physician Services in the United States | Press release | ACCESS Newswire | — | — | |
| MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada | Press release | ACCESS Newswire | — | — | |
| MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications | Press release | Accesswire | — | — | |
| MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use | Press release | Accesswire | — | — | |
| MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test | Press release | Accesswire | — | — | |
| MedMira Reports First Quarter Results FY2025 | Press release | Accesswire | — | — | |
| Canadian Investment Regulatory Organization Trade Resumption - MIR | Press release | Canada Newswire | — | — | |
| Canadian Investment Regulatory Organization Trading Halt - MIR | Press release | Canada Newswire | — | — | |
| MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV | Press release | Accesswire | — | — | |
| MedMira Reports FY2024 Fourth Quarter and Year End Financial Results | Press release | Accesswire | — | — | |
| MedMira Announces the appointment of Vice President of Commercial Operations | Press release | Accesswire | — | — | |
| Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada | Press release | Accesswire | +0.00% | +5.56% | |
| MedMira Reports Third Quarter Results FY2024 | Press release | Accesswire | +0.00% | -6.25% | |
| MedMira Announces the Hire of Vice President of Business Development | Press release | Accesswire | +0.00% | -5.88% | |
| MedMira Reports Second Quarter Results FY2024 | Press release | Accesswire | +0.00% | +0.00% | |
| MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System | Press release | Accesswire | +0.00% | +0.00% | |
| Corporate Update on Clinical Evaluation of MedMira’s Products | Press release | Accesswire | +0.00% | +0.00% | |
| CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products | Press release | Accesswire | +0.00% | +0.00% | |
| MedMira Reports First Quarter Results FY2024 | Press release | Accesswire | — | — | |
| U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test | Press release | Accesswire | +0.00% | +13.64% | |
| MedMira Reports FY2023 Fourth Quarter and Year End Financial Results | Press release | Accesswire | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MIR_CDNX section they belong to.
Where else MIR_CDNX is measured.
MIR_CDNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIONOMIC LTD PAR ORD (BNOEF) | 31 | 0.00% | 32% |
| WEED INC (BUDZ) | 31 | 0.00% | 42% |
| BIOFORCE NANOSCIENCES HLD (BFNH) | 30 | +0.30% | 50% |
| Aridis Pharmaceuticals Inc. (ARDS) | 28 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Medmira Inc's median reaction calculated?
Every labeled MIR_CDNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 31 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 10% of MIR_CDNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MIR_CDNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.